Stonybrook Center

Stonybrook Center sits in Wheaton, IL, one of the many SAMHSA-registered addiction-treatment facilities across IL. The facility offers a continuum of care across multiple levels — IOP, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The interesting questions about any specific program are rarely the ones its website answers.

Care levels at Stonybrook Center

The facility offers a continuum of care across multiple levels — IOP, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. The gap between "this facility offers residential" and "residential is the right level for this patient" is wider than most facility websites suggest. Bridge it with an outside assessment before committing.

Insurance and payment

Stonybrook Center accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Most post-treatment billing disputes trace back to a specific moment when an admissions counselor said one thing and the benefits department later documented something else. Avoid the moment by getting the written VOB before admission, not after.

Specialty programming

The facility's documented specialty programming includes: Adult women, Pregnant/postpartum women, Adult men. The gap between specialty-branding and specialty-programming is where a lot of families end up disappointed. Specific questions — who, how many hours, what credentials — close the gap before admission.

Before you call

Questions that matter before admitting to Stonybrook Center: ASAM level of care (not the facility's category, the clinical level); written VOB; MAT policy. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. The ones who answer those quickly are usually the ones worth considering. The ones who dodge are almost always worth skipping.